| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 13, 2024 | Mar 14, 2024 | Aprea Therapeutics, Inc. | Director | Buy | 95.0 | +6,860 | 536.36% | ✗ | $50K |
| May 18, 2021 | May 20, 2021 | Anika Therapeutics, Inc. | Director | Buy | 95.0 | +2,000 | 21.48% | ✗ | $85.7K |
| Oct 7, 2019 | Oct 7, 2019 | Aprea Therapeutics, Inc. | Director | Buy | 95.0 | +5,000 | 100.00% | ✗ | $75K |
| Aug 25, 2014 | Aug 26, 2014 | INTEGRA LIFESCIENCES HOLDINGS CORP | CorpVP, CAO | Sell | 17.5 | -20,000 | -36.93% | ✗ | $1M |
| May 23, 2014 | May 27, 2014 | INTEGRA LIFESCIENCES HOLDINGS CORP | CorpVP, CAO | Sell | 20.0 | -14,299 | -20.89% | ✗ | $640.9K |
| Mar 24, 2014 | Mar 26, 2014 | INTEGRA LIFESCIENCES HOLDINGS CORP | CFO | Sell | 95.0 | +14,847 | 27.69% | ✗ | $57.7K |